6
60 Degrees Pharmaceuticals, Inc. (SXTP)
NCM – Real Time Price. Currency in USD
1.50
+0.03 (2.04%)
At close: May 12, 2026, 4:00 PM EDT
1.47
-0.03 (-2.00%)
Pre-market: May 13, 2026, 5:26 AM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
1.50
+0.03 (2.04%)
At close: May 12, 2026, 4:00 PM EDT
1.47
-0.03 (-2.00%)
Pre-market: May 13, 2026, 5:26 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.66 | 6.05 | 10 | |
| Quick ratio | 2.30 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | -621.31 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 511K | 254K | 681K | 1M | 1M |
| Gross Profit | 79K | -221K | 297K | 627K | 627K |
| Operating Income | -2M | -5M | -10M | -8M | -8M |
| Net Income | -6M | -4M | -8M | -7M | -7M |
| EBITDA | -2M | -5M | -10M | -8M | -8M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 165.89 | 87.82 | 10 |
| Next quarter | 45.9 | 86.41 | 10 |
| Current year | 202.84 | 77.02 | 10 |
| Next year | 47.37 | 19.85 | 9.5 |
| Weighted average score | 9.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -40.13 | 37.8 | 28.46 | 16.36 | 7.5 |
| Y/Y | 16.22 | 29.71 | 79.19 | -8.18 | 7.5 |
| 3y average | 75.04 | -22.35 | 81.07 | -134 | 5.5 |
| 5y average | 56.47 | -30.51 | N/A | -149.33 | 3.3 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $1.5M significantly exceed its total debt $152.8K, ensuring strong financial flexibility
Total current assets $4.9M exceed Total current liabilities $1.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-621.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.8M limits the company's ability to reinvest or pay down debt